Prolixin enanthate and thorazine-stelazine regimens in the treatment of schizophrenic patients. An experimental evaluation.
D000284:Administration, Oral; D002746:Chlorpromazine / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D005476:Fluphenazine / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007267:Injections; D008297:Male; D010919:Placebos; D012559:Schizophrenia / Q000188:drug therapy*; D014268:Trifluoperazine / Q000008:administration & dosage / Q000627:therapeutic use*
D003692:Delayed-Action Preparations; D010919:Placebos; D014268:Trifluoperazine; D005476:Fluphenazine; D002746:Chlorpromazine